ConductScience.org, home

Paper · 42939746

Serum Cytokine Profiling in Pancreatic Ductal Adenocarcinoma: A Pilot Study of Candidate Discriminators, Sex Differences and Altered Co-Regulation.

García-Gómez J and 9 others. Biomolecules, 2026.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Serum Cytokine Profiling in Pancreatic Ductal Adenocarcinoma: A Pilot Study of Candidate Discriminators, Sex Differences and Altered Co-Regulation. Papers, record 42939746. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42939746

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Serum Cytokine Profiling in Pancreatic Ductal Adenocarcinoma: A Pilot Study of Candidate Discriminators, Sex Differences and Altered Co-Regulation.
Journal
Biomolecules
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-10-28

Source PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1García-Gómez JJesúshttps://orcid.org/0009-0004-5610-4041
2Agredano-Pérez SSamuel
3Rubio-Delgado DADiana Alejandrahttps://orcid.org/0009-0002-7757-5980
4Aguilar-Lemarroy AAdrianahttps://orcid.org/0000-0001-9288-4824
5Jave-Suárez LFLuis Felipehttps://orcid.org/0000-0001-6209-5031
6Guevara-Hernández SNSarah Naomi
7Bravo-Cuéllar AAlejandrohttps://orcid.org/0000-0002-2945-4503
8Méndez-Clemente ASAníbal Samaelhttps://orcid.org/0000-0001-8120-896X
9Hernández-Flores GGeorginahttps://orcid.org/0000-0002-4861-0065
10Villaseñor-García MMMaría Marthahttps://orcid.org/0000-0002-9280-7893

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Pancreatic DuctalMajor topic
CytokinesMajor topic
Pancreatic NeoplasmsMajor topic
Humans
Male
Female
Aged
Pilot Projects
Middle Aged
Interleukin-7
Biomarkers, Tumor
Sex Characteristics
Sex Factors

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
FIS/IMSS/PROT/PRIO/19/103Mexican Social Security InstitutePubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References68

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135,159,120Validation of IL-7R as an Immunological Biomarker for Human Pancreatic Ductal Adenocarcinoma.Cancers (Basel)2022https://conductscience.org/library/papers/35159120PubMed
230,106,639Serum Biomarker Signature-Based Liquid Biopsy for Diagnosis of Early-Stage Pancreatic Cancer.J Clin Oncol2018https://conductscience.org/library/papers/30106639PubMed
336,091,056Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients.Front Immunol2022https://conductscience.org/library/papers/36091056PubMed
437,857,666Development of a blood-based extracellular vesicle classifier for detection of early-stage pancreatic ductal adenocarcinoma.Commun Med (Lond)2023https://conductscience.org/library/papers/37857666PubMed
523,637,840Negative association between testosterone concentration and inflammatory markers in young men: a nested cross-sectional study.PLoS One2013https://conductscience.org/library/papers/23637840PubMed
635,850,192An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study.Gastroenterology2022https://conductscience.org/library/papers/35850192PubMed
734,366,606Pancreatic cancer: A review of epidemiology, trend, and risk factors.World J Gastroenterol2021https://conductscience.org/library/papers/34366606PubMed
829,290,757Mortality assessment of patients with pancreatic cancer in Mexico, 2000-2014.Ecancermedicalscience2017https://conductscience.org/library/papers/29290757PubMed
917,192,050Multianalyte profiling of serum cytokines for detection of pancreatic cancer.Cancer Biomark2005https://conductscience.org/library/papers/17192050PubMed
1020,210,523Interleukin-17F suppresses hepatocarcinoma cell growth via inhibition of tumor angiogenesis.Cancer Invest2010https://conductscience.org/library/papers/20210523PubMed

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first.

None in this release.

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42939746

GET https://conductscience.org/api/papers/v1/42939746/references?page=2